Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Arke Lang

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Hepatobiliary Surgery and Nutrition|August 21, 2023
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?Iakovos Amygdalos, Ulf Peter Neumann, Sven Arke Lang
Visceral Medicine|January 19, 2018
'In-Situ Split' Liver Resection/ALPPS - Historical Development and Current PracticeHans J Schlitt, Christina Hackl, Sven Arke Lang
World Journal of Gastrointestinal Oncology|December 2, 2021
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancerKatharina Joechle, Jessica Guenzle, Claus Hellerbrand, et al.
BMC Cancer|April 18, 2015
Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer modelFranziska Brandes, Katharina Schmidt, Christine Wagner, et al.
Pathology, Research and Practice|March 11, 2017
Effect of melanoma cells on proliferation and migration of activated hepatic stellate cells in vitroTheresa Meyer, Andreas Koch, Eva-Vanessa Ebert, et al.
BMC Surgery|October 31, 2018
Outcome after hepatic resection for isolated non-colorectal, non-neuroendocrine liver metastases in 100 patients - the role of the embryologic origin of the primary tumorPhilipp Anton Holzner, Frank Makowiec, Andrea Klock, et al.
Expert Review of Gastroenterology & Hepatology|December 17, 2024
The assessment of impaired liver function and prognosis in hepatocellular carcinomaRoxana Pantea, Jan Bednarsch, Sophia Schmitz, et al.
Langenbeck'S Archives of Surgery|February 26, 2008
Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental modelSven Arke Lang, Isabel Brecht, Christian Moser, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 30, 2024
Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy : A retrospective studyAhmed Allam Mohamed, Marie-Luise Berres, Philipp Bruners, et al.
Cancer Science|March 4, 2011
Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancerKarl-Hermann Schlingensiepen, Frank Jaschinski, Sven Arke Lang, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Hepatobiliary Surgery and Nutrition|August 21, 2023
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?Iakovos Amygdalos, Ulf Peter Neumann, Sven Arke Lang
Visceral Medicine|January 19, 2018
'In-Situ Split' Liver Resection/ALPPS - Historical Development and Current PracticeHans J Schlitt, Christina Hackl, Sven Arke Lang
World Journal of Gastrointestinal Oncology|December 2, 2021
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancerKatharina Joechle, Jessica Guenzle, Claus Hellerbrand, et al.
BMC Cancer|April 18, 2015
Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer modelFranziska Brandes, Katharina Schmidt, Christine Wagner, et al.
Pathology, Research and Practice|March 11, 2017
Effect of melanoma cells on proliferation and migration of activated hepatic stellate cells in vitroTheresa Meyer, Andreas Koch, Eva-Vanessa Ebert, et al.
BMC Surgery|October 31, 2018
Outcome after hepatic resection for isolated non-colorectal, non-neuroendocrine liver metastases in 100 patients - the role of the embryologic origin of the primary tumorPhilipp Anton Holzner, Frank Makowiec, Andrea Klock, et al.
Expert Review of Gastroenterology & Hepatology|December 17, 2024
The assessment of impaired liver function and prognosis in hepatocellular carcinomaRoxana Pantea, Jan Bednarsch, Sophia Schmitz, et al.
Langenbeck'S Archives of Surgery|February 26, 2008
Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental modelSven Arke Lang, Isabel Brecht, Christian Moser, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 30, 2024
Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy : A retrospective studyAhmed Allam Mohamed, Marie-Luise Berres, Philipp Bruners, et al.
Cancer Science|March 4, 2011
Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancerKarl-Hermann Schlingensiepen, Frank Jaschinski, Sven Arke Lang, et al.
Pageof 5